Table 4.
Bivariate and multivariate Cox regression of selected demographic and clinical characteristics for predictors of survival among children with retinoblastoma.
| Variable | CHR (95% CI) | AHR (95% CI) | P value |
|---|---|---|---|
| Age group at first sign in months | |||
| 0 to 12 | 1 | 1 | |
| 13 to 36 | 1.08 (0.48 − 2.40) | 0.89 (0.33 − 2.26) | 0.772 |
| Over 36 | 1.08 (0.45 − 2.58) | 0.40 (0.14 − 1.13) | 0.084 |
| Sex: Male | 1.04 (0.52 − 2.04) | 1.12 (0.54 − 2.31) | 0.769 |
| Eye loss | |||
| No | 1 | 1 | |
| 1 eye enucleated | 1.40 (0.67 − 2.94) | 1.12 (0.51 − 2.45) | 0.779 |
| Both eyes enucleated | 3.94 (1.64 − 9.46) | 3.53 (1.33–9.36) | 0.011 |
| Metastatic spread | |||
| No | 1 | 1 | |
| Yes | 9.24 (3.88–22.02) | 8.93 (3.23–24.69) | 0.001 |
| Lag time between first sign and UCI visit in months | |||
| 0 to 6 | 1 | 1 | |
| 7 and above | 0.18 (0.07 − 0.42) | 0.10 (0.04 − 0.25) | 0.001 |
| Proptosis | |||
| No | 1 | 1 | |
| Yes | 1.65 (0.82–3.31) | 1.35 (0.52–3.48) | 0.535 |
| Eye swelling | |||
| No | 1 | ||
| Yes | 2.62 (1.10–6.27) | 4.39 (1.38–14.01) | 0.012 |
| Eye reddening | |||
| No | 1 | 1 | |
| Yes | 1.65 (0.73–3.70) | 0.36 (0.14–0.94) | 0.036 |